Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …

Address correspondence to: Zelma C. Chiesa-Fuxench, Department of Dermatology,
University of Puerto Rico School of Medicine, PO Box 365067 San Juan, Puerto Rico 00936 …

Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Introduction: Extracorporeal photopheresis (ECP) has been extensively used for the
treatment of immune-mediated diseases for over 20 years and has a consistent and …

Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …

Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

Extracorporeal photopheresis (ECP) is a well‐tolerated procedure that suppresses T‐
lymphocyte activity in a clonally‐specific way. It is an effective therapy that has established …

The immune system is tasked with the unique challenge of recognizing foreign pathogens
and damaged cells while at the same time preserving and protecting the integrity of “self” …

This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …